Key terms
About AZN
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AZN news
May 30
9:59am ET
PayPal upgraded, UiPath downgraded: Wall Street’s top analyst calls
May 30
8:56am ET
AstraZeneca price target raised to $85 from $80 at Argus
May 30
7:11am ET
Compugen to receive $5M milestone payment from AstraZeneca
May 30
4:35am ET
AstraZeneca initiated with a Buy at Goldman Sachs
May 29
4:12pm ET
Fusion Pharmaceuticals shareholders approve acquisition by AstraZeneca
May 29
12:45pm ET
Jefferies sees ‘key nuance’ in comparing NewAmsterdam to AstraZeneca data
May 28
6:29am ET
AstraZeneca says Dato-DXd showed meaningful OS improvement in trial
May 24
12:54pm ET
AstraZeneca price target raised to 14,500 GBp from 14,000 GBp at Morgan Stanley
May 24
11:22am ET
Jefferies healthcare analyst holds an analyst/industry conference call
May 24
1:52am ET
AstraZeneca’s Growth Trajectory: A Buy Rating Justified by Strong Pipeline and Revenue Targets
May 21
8:01am ET
AstraZeneca (NASDAQ:AZN) Aims for $80B Annual Revenue by 2030
May 21
5:32am ET
AstraZeneca announces $80B revenue target by 2030
May 21
4:55am ET
AstraZeneca to host investor day
May 20
5:17pm ET
AstraZeneca to host investor day
May 20
3:45pm ET
AstraZeneca call volume above normal and directionally bullish
May 20
6:11am ET
AstraZeneca plans to build $1.5B manufacturing facility for ADCs in Singapore
May 19
6:01pm ET
Amgen announces results of Phase 2a COURSE trial evaluating Tezspire
May 16
7:30am ET
AstraZeneca’s New Antibody Shields the Immunocompromised
May 16
7:20am ET
Analysts’ Top Healthcare Picks: AstraZeneca (AZN), Aprea Therapeutics (APRE)
May 16
6:15am ET
AstraZeneca reports SUPERNOVA trial of sipavibart met COVID prevention endpoint
May 15
10:57am ET
AstraZeneca CEO Granted Performance Shares
May 08
6:32am ET
AstraZeneca withdraws Covid vaccine worldwide, Independent says
May 07
2:16pm ET
AstraZeneca price target raised to 13,000 GBp from 12,000 GBp at Berenberg
May 07
7:57am ET
AstraZeneca Advances in Gene Therapy with Cellectis Stake
May 07
1:25am ET
AstraZeneca (AZN) Gets a Buy from Berenberg Bank
May 06
5:23am ET
Cellectis announces completion of $140M investment from AstraZeneca
May 02
7:31am ET
AstraZeneca’s Calquence Shows Promise in Lymphoma Trial
May 02
6:21am ET
AstraZeneca announces results from interim analysis of ECHO Phase III trial
May 02
2:17am ET
AstraZeneca: Strong Q1 Earnings and Promising Pipeline Reinforce Buy Rating
May 01
1:15pm ET
AstraZeneca put volume heavy and directionally bearish
May 01
12:02pm ET
AstraZeneca Shares Voting Rights Update
No recent press releases are available for AZN
AZN Financials
Key terms
Ad Feedback
AZN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AZN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
